← Leaderboards
Manubai Nagamani
University Of Texas Medical Br Galveston
$598,504
Attributed
$598,504
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$598,504 · 2
By mechanism
M01$598,504 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Medical Br Galveston
Same institution · by research overlap
- Ayman Al-Hendy$16,587,078
- Lee-Jane W Lu$7,395,875
- Chandrasekhar Yallampalli$13,869,177
- Randall J Urban$29,729,784
- John Nmn Papaconstantinou$5,871,511
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingClinical ResearchFemaleHuman SubjectInsulin Sensitivity /ResistancePostmenopauseHyperinsulinismInsulinInsulinlike Growth FactorUterus NeoplasmsCancer RiskEndometriumHormone Regulation /Control MechanismHormone Related Neoplasm /CancerGlucose Tolerance TestGlucose Clamp TechniqueMenopauseHormone TherapyRaloxifeneHuman Therapy Evaluation
Grant awards (5)
EFFECT OF RALOXIFENE ON INSULIN SENSITIVITY IN NORMAL POSTMENOPAUSAL WOMEN$3,799
M01 · FY2005 · RR
Effect of raloxifene on insulin sensitivity in normal postmenopausal women$1,914
M01 · FY2004 · RR
OVARIAN STEROIDS IN MENOPAUSAL WOMEN WITH ENDOMETRIAL CANCER$279,290
M01 · FY2002 · RR
OVARIAN STEROIDS IN MENOPAUSAL WOMEN WITH ENDOMETRIAL CANCER$279,290
M01 · FY2001 · RR
OVARIAN STEROIDS IN MENOPAUSAL WOMEN WITH ENDOMETRIAL CANCER$34,211
M01 · FY2000 · RR